skip to main content
Close Icon We use cookies to improve your website experience.  To learn about our use of cookies and how you can manage your cookie settings, please see our Cookie Policy.  By continuing to use the website, you consent to our use of cookies.
Global Search Configuration

WASHINGTON - JULY 18: A sign at the entrance to a Senate Health, Education, Labor, and Pensions Committee room in Washington, DC on July 18, 2017. The Senate is the upper chamber of the US Congress.

US senators have been churning out bills to address different problems created by the COVID-19 crisis this spring, and spent much of a 23 June Health, Education, Labor and Pensions (HELP) Committee hearing explaining the legislative measures they would put in place to fix the pandemic’s medical and societal dilemmas, and contain similar pandemics in the future.

Below is a chart summarizing varying approaches the lawmakers would take to solve a number of crises created by the coronavirus pandemic, and the legislation’s potential impact on industry.

Proposed Senate Laws Aimed At Solving, Preventing Another COVID-19-Like Crisis


Bill Name
Emergency Family Standards Act
Build Health Care Equipment in America Act
Coronavirus Containment Corps Act
Ensuring Understanding Of COVID-19 To Protect Health Act
COVID-19 Every Workers Protection Act
Date Introduced 10-Jun-20 19-May-20 14-May-20 4-May-20 11-May-20
Impact On Medtech Industry Calls for purchase of extra personal protective equipment (PPE) and hygiene supplies for children under 25 whose families were impacted by the virus, and more medical, dental care of children, pregnant women. Would increase production of additional COVID-19 diagnostics and test supplies, masks, PPE and ventilators within the US, and call for construction of more US medtech factories to make COVID-19 supplies. Bill would provide $10bn to hire contact tracers to look at Centers for Disease Control and Prevention test results to identify patients with the virus and carry out additional testing on each COVID-19 patient contact found. Study would use advanced imaging and other devices to examine how lung, cardiovascular and brain function might have been impaired by the COVID-19 virus. Employers would have to set OSHA plan to protect employees from COVID-19 exposures on the job and buy additional PPE, shields, masks and disinfectants for workers.
Bill Number S.3923 S.3757 No bill number yet in Senate; it is a companion bill to H.R.6871 in the House S.3595 S.3677
Sponsor Sen. Lisa Murkowski (R-AK) Sen. Doug Jones (D-AL) Sen. Elizabeth Warren (D-MA) and Rep. Carl Levin (D-MI) Sen. Jacky Rosen (D-NV) Sen. Tammy Baldwin (D-WI)
Purpose To provide emergency coronavirus protection supplies and relief to youth, families experiencing homelessness due to COVID-19 illness, or through related job losses. Incentivizes US companies through tax credits, grants and deductions to build new COVID-19 medical equipment, supply, diagnostic factories in US and to ramp up production of needed supplies at existing US factories. Would establish a corps of contact tracers and COVID-19 investigators in US to use electronic health records and hospital equipment user data to help identify new potential COVID-19 cases. Calls for a National Institutes of Health 10-year longitudinal study to assess the impact of COVID-19 on those infected, including lung damage and capacity, and impact on several biological systems. Requires the Occupational Safety and Health Administration to set rules for employer plans to protect health care providers, first responders and other crucial employees from being infected with COVID-19.

Read also


Next steps

Whether you’re a small biotech start-up, research firm, generic manufacturer or a global pharmaceutical giant, you need focused, independent insight and opinion on market developments.

Our team is always happy to hear from you. Please call us at:

  • US Toll-Free  : +1 888 670 8900
  • US Toll           : +1 908 547 2200
  • UK & Europe : +44 (20) 337 73737
  • Australia        : +61 2 8705 6907
  • Japan              : +81 3 6273 4260

Or please submit your inquiry via the form so that we can provide you the best possible customer service.

Have an immediate and specific information need?

Browse and buy from 1000s of analysis and research reports now: